Thomas Kassberg

2019

In 2019, Thomas Kassberg earned a total compensation of $2.5M as Chief Business Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 45% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$206,901
Option Awards$863,513
Salary$474,000
Stock Awards$878,150
Other$33,937
Total$2,456,501

Kassberg received $878.2K in stock awards, accounting for 36% of the total pay in 2019.

Kassberg also received $206.9K in non-equity incentive plan, $863.5K in option awards, $474K in salary and $33.9K in other compensation.

Rankings

In 2019, Thomas Kassberg's compensation ranked 4,942nd out of 13,971 executives tracked by ExecPay. In other words, Kassberg earned more than 64.6% of executives.

ClassificationRankingPercentile
All
4,942
out of 13,971
65th
Division
Manufacturing
1,841
out of 5,695
68th
Major group
Chemicals And Allied Products
649
out of 2,194
70th
Industry group
Drugs
548
out of 1,880
71st
Industry
Pharmaceutical Preparations
411
out of 1,392
71st
Source: SEC filing on April 29, 2020.

Kassberg's colleagues

We found four more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2019.

2019

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2019

John Pinion

Ultragenyx Pharmaceutical

Chief Quality Officer and Executive Vice President, Translational Sciences

2019

Shalini Sharp

Ultragenyx Pharmaceutical

Chief Financial Officer

2019

Camille Bedrosian

Ultragenyx Pharmaceutical

Chief Medical Officer

News

You may also like